NCT00470548 - Abraxane and Alimta in Advanced Solid Tumors | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

April 30, 2007

Primary Completion Date

October 31, 2014

Study Completion Date

October 31, 2014

Conditions

Breast CancerLung CancerUnspecified Adult Solid Tumor, Protocol Specific

Interventions

DRUG

Abraxane

ABI-007 IV administration following pemetrexed on Day 1 of each cycle (infused over 30 minutes)

DRUG

Alimta

Pemetrexed IV administration on Day 1 of each cycle (infused over 10 minutes)

Trial Locations (1)

University of California Davis Cancer Center, Sacramento